Beyond the Petri dish: Testing tomorrow's drugs in human blood
The COVID vaccine is perhaps the first thing many people think of when they hear about mRNA-based drugs. Small packages of genetic material are sent into the body, prompting cells to produce useful proteins in the fight against the virus. But the list of diseases that can potentially be treated with mRNA-based drugs is much broader than vaccines. mRNA is expected to be used to treat disorders including cardiovascular diseases, rare hereditary diseases and autoimmune diseases—and not least,…
Phys.org
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Phys.org.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Phys.org (phys.org), a Tier B publisher, filed this report on . CurrentWire published this page 1 minute later, on .
Signal breakdown
CurrentWire ranked this story 60.1 of 100 in the snapshot this page was rendered from.
- Freshness
- 30.6 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 30.6 of 35. How each signal is calculated.
Filed under Health · International · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: COVID-19 (1).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.